Loading…
Canopy Growth Corp
Canopy Growth Corp (CGC) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Smiths Falls, Canada and has 1,128 employees. The company is worth $298.92M. Revenue was CA$284.6M in fiscal 2026, up 5.8% from the year before. It reported a net loss of CA$262.91M. The share price is 72.0% below its 52-week high of $2.38. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Israel Englander (Millennium Management), at $470.54K. In that quarter, 1 of them reduced the position. Over the last 30 days, company insiders sold $37.44K of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Revenue, debt and profit are in CAD, the currency the company reports in — not converted to dollars. Dividends are in dollars.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▼ -99.3% over 5Y.
today you would have $5.65▼ -99.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Year-end price | $0.71 | $1.14 | $2.74 | $5.11 | |
| EPS | -CA$0.88 | -CA$5.56 | -CA$9.27 | -CA$70.69 | |
| Profit margin | -211.31% | -92.38% | -189.18% | -233.45% | -983.68% |
| ROE | -139.78% | -37.69% | -106.33% | -173.24% | -432.23% |
This company reports in CAD, and the stock trades in dollars. P/E, P/S, P/B and payout would divide dollars by CAD, so they are not shown; EPS is in CAD. Margin, ROE and dividend yield do not depend on the currency.
Median of the years shown; P/E years above 200x are left out.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| GLASGlass House Brands Inc. | $3.19 | — | 3.9x | 0.00% | -28.58% | $300.63M |
| AGENAgenus Inc | $6.51 | 2.6x | — | 0.00% | — | $294M |
| SMTISanara MedTech Inc. | $33.16 | — | 38.4x | 0.00% | -1.32% | $304.68M |
| ARCTArcturus Therapeutics Holdings Inc. | $10.73 |
| — |
| 1.8x |
| 0.00% |
| -46.31% |
| $304.98M |
| ARTVArtiva Biotherapeutics, Inc. | $5.85 | — | 0.8x | 0.00% | -36.58% | $286.01M |
| BNTCBenitec Biopharma Inc. | $8.11 | — | 1.6x | 0.00% | -33.21% | $282.9M |